The tumor-suppressing signaling lipid ceramide is elevated upon FASN inhibition in 231MFP cells [12] and this is consistent with our data showing increased levels of ceramide and hexaceramide in Pt 2402 and Pt 2449PT, respectively. The gene discussed is FASN; the disease is neoplasm.